The role of neuraminidase 1 (NEU1) in cytokine release by primary mouse mesangial cells and disease outcomes in murine lupus nephritis

References

• Nowling TK, Mather AR, Thiyagarajan T, et al. Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis. J Am Soc Nephrol. 2015;26(6):1402–1413.
   PubMed Web of Science ®Google Scholar
• Sundararaj K, Rodgers JI, Marimuthu S, et al. Neuraminidase activity mediates IL-6 production by activated lupus-prone mesangial cells. Am J Physiol Renal Physiol. 2018;314(4):F630–F642.
   PubMed Web of Science ®Google Scholar
• Monti E, Bassi MT, Papini N, et al. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem J. 2000;349(Pt 1):343–351.
   PubMedGoogle Scholar
• Yamaguchi K, Hata K, Koseki K, et al. Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J. 2005;390(Pt 1):85–93.
   PubMedGoogle Scholar
• Bonten E, van der Spoel A, Fornerod M, et al. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 1996;10(24):3156–3169.
   PubMed Web of Science ®Google Scholar
• Comelli EM, Amado M, Lustig SR, et al. Identification and expression of Neu4, a novel murine sialidase. Gene. 2003;321:155–161.
   PubMed Web of Science ®Google Scholar
• Koseki K, Wada T, Hosono M, et al. Human cytosolic sialidase NEU2-low general tissue expression but involvement in PC-3 prostate cancer cell survival. Biochem Biophys Res Commun. 2012;428(1):142–149.
   PubMed Web of Science ®Google Scholar
• Kotani K, Kuroiwa A, Saito T, et al. Cloning, chromosomal mapping, and characteristic 5'-UTR sequence of murine cytosolic sialidase. Biochem Biophys Res Commun. 2001;286(2):250–258.
   PubMed Web of Science ®Google Scholar
• Sundararaj K, Rodgers J, Angel P, et al. The role of neuraminidase in TLR4-MAPK signaling and the release of cytokines by lupus serum-stimulated mesangial cells. Immunology. 2020.doi: 10.1111/imm.13294.
   Web of Science ®Google Scholar
• Takemura T, Yoshioka K, Murakami K, et al. Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch. 1994;424(5):459–464.
   PubMed Web of Science ®Google Scholar
• Kiberd BA. Interleukin-6 receptor blockage ameliorates murine lupus nephritis. J Am Soc Nephrol. 1993;4:58–61.
   PubMed Web of Science ®Google Scholar
• Herrera-Esparza R, Barbosa-Cisneros O, Villalobos-Hurtado R, et al. Renal expression of IL-6 and TNFalpha genes in lupus nephritis. Lupus. 1998;7(3):154–158.
   PubMed Web of Science ®Google Scholar
• Malide D, Russo P, Bendayan M. Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol. 1995;26(5):558–564.
   PubMed Web of Science ®Google Scholar
• Liang B, Gardner DB, Griswold DE, et al. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology. 2006;119(3):296–305.
   PubMed Web of Science ®Google Scholar
• Cash H, Relle M, Menke J, et al. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol. 2010;37(1):60–70.
   PubMed Web of Science ®Google Scholar
• Dos Santos M, Poletti PT, Favero G, et al. Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis. Autoimmunity. 2018;51(2):69–80.
   PubMed Web of Science ®Google Scholar
• Nowling TK, Rodgers J, Thiyagarajan T, et al. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice. PLoS One. 2020;15(3):e0230499.
   PubMed Web of Science ®Google Scholar
• Morel L, Croker BP, Blenman KR, et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA. 2000;97(12):6670–6675.
   PubMed Web of Science ®Google Scholar
• Morel L, Mohan C, Yu Y, et al. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol. 1997;158:6019–6028.
   PubMed Web of Science ®Google Scholar
• Morel L, Yu Y, Blenman KR, et al. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome. 1996;7(5):335–339.
   PubMed Web of Science ®Google Scholar
• Dietrich W, Katz H, Lincoln SE, et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics. 1992;131(2):423–447.
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675.
   PubMed Web of Science ®Google Scholar
• Varghese F, Bukhari AB, Malhotra R, et al. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 2014;9(5):e96801.
   PubMed Web of Science ®Google Scholar
• de Geest N, Bonten E, Mann L, et al. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet. 2002;11(12):1455–1464.
   PubMed Web of Science ®Google Scholar
• Chafin CB, Regna NL, Dai R, et al. MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro. Autoimmunity. 2013;46(6):351–362.
   PubMed Web of Science ®Google Scholar
• Masson E, Wiernsperger N, Lagarde M, et al. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem J. 2005;388(Pt 2):537–544.
   PubMedGoogle Scholar
• Tsuboi N, Utsunomiya Y, Kawamura T, et al. Ganglioside as an endogenous growth suppressor for glomerular mesangial cells. Kidney Int. 2001;60(4):1378–1385.
   PubMed Web of Science ®Google Scholar
• Sundararaj KP, Thiyagarajan T, Molano I, et al. FLI1 levels impact CXCR3 expression and renal infiltration of T cells and renal glycosphingolipid metabolism in the MRL/lpr lupus mouse strain. J Immunol. 2015;195(12):5551–5560.
   PubMed Web of Science ®Google Scholar
• Richard EM, Thiyagarajan T, Bunni MA, et al. Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism. PLoS One. 2013;8(9):e75175.
   PubMed Web of Science ®Google Scholar
• Jury EC, Kabouridis PS, Flores-Borja F, et al. Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J Clin Invest. 2004;113(8):1176–1187.
   PubMed Web of Science ®Google Scholar
• Katoh S, Maeda S, Fukuoka H, et al. A crucial role of sialidase Neu1 in hyaluronan receptor function of CD44 in T helper type 2-mediated airway inflammation of murine acute asthmatic model. Clin Exp Immunol. 2010;161(2):233–241.
   PubMed Web of Science ®Google Scholar
• Nan X, Carubelli I, Stamatos NM. Sialidase expression in activated human T lymphocytes influences production of IFN-gamma. J Leukoc Biol. 2007;81(1):284–296.
   PubMed Web of Science ®Google Scholar
• Diao L, Tao J, Wang Y, et al. Co-delivery of dihydroartemisinin and HMGB1 siRNA by TAT-modified cationic liposomes through the TLR4 signaling pathway for treatment of lupus nephritis. Int J Nanomedicine. 2019;14:8627–8645.
   PubMed Web of Science ®Google Scholar
• Patole PS, Pawar RD, Lech M, et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Eur Renal Assoc. 2006;21:3062–3073.
   Google Scholar
• Sung SJ, Fu SM. Interactions among glomerulus infiltrating macrophages and intrinsic cells via cytokines in chronic lupus glomerulonephritis. J Autoimmun. 2020;106:102331.
   PubMed Web of Science ®Google Scholar
• Amith SR, Jayanth P, Finlay T, et al. Detection of Neu1 sialidase activity in regulating Toll-like receptor activation. J Vis Exp. 2010;43:2142.
   Google Scholar
• Allendorf DH, Franssen EH, Brown GC. Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of toll-like receptor 4. J Neurochem. 2020;155(4):403–416.
   PubMed Web of Science ®Google Scholar
• Allendorf DH, Puigdellivol M, Brown GC. Activated microglia desialylate their surface, stimulating complement receptor 3-mediated phagocytosis of neurons. Glia. 2020;68(5):989–998.
   PubMed Web of Science ®Google Scholar
• Rusciani A, Duca L, Sartelet H, et al. Elastin peptides signaling relies on neuraminidase-1-dependent lactosylceramide generation. PLoS One. 2010;5(11):e14010.
   PubMed Web of Science ®Google Scholar
• Natori Y, Nasui M, Edo K, et al. NEU1 sialidase controls gene expression and secretion of IL-6 and MCP-1 through NF-κB pathway in 3T3-L1 adipocytes. J Biochem. 2017;162(2):137–143.
   PubMed Web of Science ®Google Scholar
• Wang D, Ozhegov E, Wang L, et al. Sialylation and desialylation dynamics of monocytes upon differentiation and polarization to macrophages. Glycoconj J. 2016;33(5):725–733.
   PubMed Web of Science ®Google Scholar
• Stamatos NM, Liang F, Nan X, et al. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. Febs J. 2005;272(10):2545–2556.
   PubMed Web of Science ®Google Scholar
• Smutova V, Albohy A, Pan X, et al. Structural basis for substrate specificity of mammalian neuraminidases. PLoS One. 2014;9(9):e106320.
   PubMed Web of Science ®Google Scholar
• Miyagi T, Wada T, Iwamatsu A, et al. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J Biol Chem. 1999;274(8):5004–5011.
   PubMed Web of Science ®Google Scholar
• Papini N, Anastasia L, Tringali C, et al. The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions. J Biol Chem. 2004;279(17):16989–16995.
   PubMed Web of Science ®Google Scholar
• Seyrantepe V, Demir SA, Timur ZK, et al. Murine sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease. Exp Neurol. 2018;299(Pt A):26–41.
   PubMedGoogle Scholar
• Bonardi D, Papini N, Pasini M, et al. Sialidase NEU3 dynamically associates to different membrane domains specifically modifying their ganglioside pattern and triggering Akt phosphorylation. PLoS One. 2014;9(6):e99405.
   PubMed Web of Science ®Google Scholar
• Huizing M, Yardeni T, Fuentes F, et al. Rationale and design for a phase 1 study of N-acetylmannosamine for primary glomerular diseases. Kidney Int Rep. 2019;4(10):1454–1462.
   PubMed Web of Science ®Google Scholar
• Feng C, Stamatos NM, Dragan AI, et al. Sialyl residues modulate LPS-mediated signaling through the toll-like receptor 4 complex. PLoS One. 2012;7(4):e32359.
   PubMed Web of Science ®Google Scholar
• Vorobyev A, Gupta Y, Sezin T, et al. Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse line. Nat Commun. 2019;10(1):4097.
   PubMedGoogle Scholar
• Miyake K, Adachi K, Watanabe M, et al. Parasites alter the pathological phenotype of lupus nephritis. Autoimmunity. 2014;47(8):538–547.
   PubMed Web of Science ®Google Scholar
• Manirarora JN, Kosiewicz MM, Alard P. Feeding lactobacilli impacts lupus progression in (NZBxNZW)F1 lupus-prone mice by enhancing immunoregulation. Autoimmunity. 2020;53(6):323–332.
   PubMed Web of Science ®Google Scholar